Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
08/2003
08/26/2003US6610877 Treating photo and/or age damaged skin
08/26/2003US6610847 Tyrosine kinase inhibitors; immunosuppressants
08/26/2003US6610821 Cyclic peptide of given amino acid sequence; can use to improve drug delivery process, inhibit angiogenesis, increase vasopermeability; treatment of autoimmune and inflammatory diseases
08/26/2003US6610820 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
08/26/2003US6610744 Methods of treatment with compounds having RARα receptor specific or selective activity
08/26/2003US6610742 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
08/26/2003US6610737 Non-psychotropic cannabinoids
08/26/2003US6610724 3-Aminopyrazole inhibitors of cyclin dependent kinases
08/26/2003US6610716 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
08/26/2003US6610715 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
08/26/2003US6610711 4-phenylpiperidines for the treatment of pruritic dermatoses
08/26/2003US6610700 Inhibit binding of integrins to their ligands, use in immune or inflammatory disorders; 3-(4-((2,6-Naphthyridinyl)amino)-phenyl)-2-((2-(1-ethylpropyl)-3-oxo-1 -cyclopentenyl) amino)-propionic acid, for example
08/26/2003US6610697 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-a]pyrimidines, and related pharmaceutical compositions and methods
08/26/2003US6610695 Prophylaxis or treatment of CSBP/RK/p38 kinase mediated disease
08/26/2003US6610683 Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
08/26/2003US6610674 Method of treating inflammatory conditions with progesterone analogs
08/26/2003US6610665 2-(purin-9-yl)-tetrahydrofuran-3, 4-diol derivatives
08/26/2003US6610523 Human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/26/2003US6610284 Preparation for prevention and healing of inflammation affections
08/26/2003CA2277896C Preparation of collagen
08/25/2003CA2405347A1 Medicament comprising nk4 gene or recombinant nk4 protein
08/21/2003WO2003068937A2 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
08/21/2003WO2003068813A2 Group b streptococcus antigen
08/21/2003WO2003068812A2 Immune-modulating peptide made of s. aureus enterotoxin b
08/21/2003WO2003068803A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003WO2003068759A1 Piperazine derivatives as anti-inflammatory agents
08/21/2003WO2003068750A1 Jnk inhibitor
08/21/2003WO2003068749A1 Vanilloid receptor modulators
08/21/2003WO2003068747A1 Nicotinamide derivates useful as p38 inhibitors
08/21/2003WO2003068744A1 Pyridine derivatives or salts thereof and cytokine production inhibitors containing the same
08/21/2003WO2003068743A1 Chemical compounds
08/21/2003WO2003068738A1 Pyrrole derivatives as ligands of melanocortin receptors
08/21/2003WO2003068316A1 Cosmetic formulations that contain antimicrobial polymers
08/21/2003WO2003068287A1 Compositions comprising undifferentiated fetal cells for the treatment of skin disorders
08/21/2003WO2003068281A1 Composition for skin healing comprising a chitosan hydrogel
08/21/2003WO2003068250A1 Compositions and methods for treatment of skin disorders
08/21/2003WO2003068248A1 Cell delivery system
08/21/2003WO2003068243A1 Carbohydrate-based anti-wrinkle and tissue remodelling compounds
08/21/2003WO2003068237A1 Beta-sheet mimetics and composition and methods relating thereto
08/21/2003WO2003068235A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068234A1 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
08/21/2003WO2003068232A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068230A1 Substituted pyridinones as modulators of p38 map kinase
08/21/2003WO2003068228A1 Aryl ureas with angiogenesis inhibiting activity
08/21/2003WO2003068225A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn$g(g)
08/21/2003WO2003068223A1 Aryl ureas with raf kinase and angiogenesis inhibiting activity
08/21/2003WO2003068217A1 Biphenil derivatives and their use as antiandrogenic agents
08/21/2003WO2003068210A1 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
08/21/2003WO2003068202A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
08/21/2003WO2003068171A2 Method and composition for treatment of inflammation and aids-associated neurological disorders
08/21/2003WO2003068161A2 Composition and method for protecting labile active components
08/21/2003WO2003068141A2 Cosmetic or dermopharmaceutical compositions which are used to reduce bags and circles under the eyes
08/21/2003WO2003067991A1 Compositions and methods for treatment of microbial infections
08/21/2003WO2003067988A1 Aqueous antiseptic based on bispyridiniumalkanes
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2003027075A3 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
08/21/2003WO2003024474A3 Anti-inflammatory agent
08/21/2003WO2003020751A3 Homing peptides
08/21/2003WO2003007930A3 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
08/21/2003WO2002092620A3 Peptides and related molecules that bind to tall-1
08/21/2003WO2002089917A3 Dermatological formulations
08/21/2003WO2002088664A3 Control of compactability through crystallization
08/21/2003WO2002085384A3 Lubricious coatings for substrates
08/21/2003WO2002064748A3 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2003WO2002057452A3 Human proteins, polynucleotides encoding them and methods of using the same
08/21/2003WO2002046158A3 Piperidine/piperazine-type inhibitors of p38 kinase
08/21/2003WO2002036573A3 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
08/21/2003US20030159163 Transgenic animal; animal models; gene expression; skin disorders
08/21/2003US20030158409 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
08/21/2003US20030158381 Novel insulin/igf/relaxin family polypeptides and dnas thereof
08/21/2003US20030158266 Particularly septic shock
08/21/2003US20030158238 Treating diseases such as cancer, inflammatory disorders, restenosis,
08/21/2003US20030158226 Treating or preventing emphysema, cancer and dermatological disorders
08/21/2003US20030158225 Novel compounds
08/21/2003US20030158217 Succinate and malonate complexes treatment of abnormal cell growth, such as cancer, and overexpression of erbB2, and inducing cell death
08/21/2003US20030158209 Amidomethylcarbonyl-substituted piperazine derivatives containing additional amine groups, useful in treating eating, sexual and skin disorders
08/21/2003US20030158204 Diamino phenothiazine derivatives and composition comprising same
08/21/2003US20030158192 Activating cytokine biosynthesis, viricides treating a viral disease, antitumor agents, immunomodulators
08/21/2003US20030158189 Non-steroidal antiinflammatory agents treating bone disorders, Crohn's disease, and inflammatory bowel disease, respiratory disorders such as chronic obstructive pulmonary disease, infections, autoimmune diseases
08/21/2003US20030158187 Genetic polymorphisms in the preprotachy kinin gene
08/21/2003US20030158178 Heterocyclic retinoid compounds
08/21/2003US20030158173 NK 1 antagonists
08/21/2003US20030158164 Novel antiandrogenic agent
08/21/2003US20030158125 Polysaccharidic esters of n-derivatives of glutamic acid
08/21/2003US20030158123 Purified material having size and growth inhibitory effects on cells and tissues
08/21/2003US20030158099 Cancer therapy
08/21/2003US20030158096 Novel molecule
08/21/2003US20030157204 A plant extracts as immunomodulator treating autoimmune disorders, antiallergens treating hypersensitivity reactions; used as pharmaceuticals, cosmetics or dietary supplements
08/21/2003US20030157200 Use of oligosaccharides to stimulate beta-endorphin production
08/21/2003US20030157144 Desaturase genes and uses thereof
08/21/2003US20030157138 Pharmaceutical or cosmetic carrier or composition for topical application onto skin and/or mucosal membranes; treatment of skin diseases or disorders including eczema, psoriasis and dermatitis
08/21/2003US20030157108 80-100% of the glycoprotein has a mature core carbohydrate structure which lacks fucose, attached to a Fc region
08/21/2003US20030157088 Mixture of enzyme and enzyme inhibitors
08/21/2003US20030157084 Methods for preparing purified prostaglandin E synthase
08/21/2003US20030157055 Modified cytokines for use in cancer therapy
08/21/2003US20030157037 Use of aryl oximes for the prophylaxis and/or treatment of erythema formation and/or inflammatory reaction of the skin
08/21/2003US20030157036 Topical dapsone for the treatment of acne
08/21/2003US20030155434 Spray nozzle apparatus and method of use
08/21/2003CA2476553A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
1 ... 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 ... 1065